Biotechnology Novo Nordisk’s Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments – Novo Nordisk (OTC:NONOF), Novo Nordisk (NYSE:NVO) Read more
Biotechnology Amgen Stock Adds Good Weight After CEO’s Update On Experimental Drug Rivaling Ozempic, Nixing Oral Weight-Loss Candidate – Amgen (NASDAQ:AMGN) Read more
Biotechnology Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation – Regeneron Pharmaceuticals (NASDAQ:REGN) Read more
Biotechnology Changing Frugal Eating Habits – How Novo Nordisk/Eli Lilly’s Weight Loss Drugs Reshaping Food Spending – Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025 – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Eli Lilly Suffers Legal Loss For Its Popular Weight Loss/Diabetes Drug In Lawsuit Against Florida Compounding Pharmacy – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Bristol Myers’ $14B Bet On Schizophrenia – Drug Cuts Symptoms Without Common Side Effect Of Weight Gain Associated With Other Antipsychotics – Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology Elevance, CVS Health Are First Medicare Insurers To Cover Novo Nordisk’s Weight Loss Sensation Wegovy – CVS Health (NYSE:CVS), Novo Nordisk (NYSE:NVO), Elevance Health (NYSE:ELV) Read more
Biotechnology Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions – Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY) Read more